Cargando…
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
BACKGROUND: Total circulating soluble receptor for advanced glycation endproducts (sRAGE) and a more defined endogenous secretory splice variant of the receptor (esRAGE) were shown to be associated with different markers of cardiovascular risk in patients with diabetes. Since previous data were part...
Autores principales: | Humpert, Per M, Djuric, Zdenka, Kopf, Stefan, Rudofsky, Gottfried, Morcos, Michael, Nawroth, Peter P, Bierhaus, Angelika |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1821011/ https://www.ncbi.nlm.nih.gov/pubmed/17343760 http://dx.doi.org/10.1186/1475-2840-6-9 |
Ejemplares similares
-
Regulation of osteoclast function and bone mass by RAGE
por: Zhou, Zheng, et al.
Publicado: (2006) -
Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study
por: Oikonomou, Dimitrios, et al.
Publicado: (2014) -
The Complexity of Sporadic Alzheimer's Disease Pathogenesis: The Role of RAGE as Therapeutic Target to Promote Neuroprotection by Inhibiting Neurovascular Dysfunction
por: Perrone, Lorena, et al.
Publicado: (2012) -
RAGE signaling sustains inflammation and promotes tumor development
por: Gebhardt, Christoffer, et al.
Publicado: (2008) -
Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
por: Bopp, Christian, et al.
Publicado: (2008)